 Johan Van Hove
Concepts (313)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperglycinemia, Nonketotic | 10 | 2026 | 56 | 4.610 |
Why?
| | Mitochondrial Diseases | 8 | 2025 | 92 | 2.520 |
Why?
| | Glycine | 6 | 2026 | 186 | 2.360 |
Why?
| | DNA, Mitochondrial | 7 | 2025 | 212 | 2.050 |
Why?
| | Epilepsy | 8 | 2022 | 386 | 1.590 |
Why?
| | Aldehyde Dehydrogenase | 7 | 2022 | 99 | 1.370 |
Why?
| | Cardiomyopathies | 3 | 2024 | 334 | 1.350 |
Why?
| | Mitochondrial Proteins | 5 | 2021 | 262 | 1.320 |
Why?
| | Mutation | 17 | 2024 | 4068 | 1.250 |
Why?
| | Acyl-CoA Dehydrogenases | 2 | 2024 | 12 | 1.030 |
Why?
| | Pyridoxine | 6 | 2022 | 37 | 0.950 |
Why?
| | Mitochondria | 6 | 2021 | 981 | 0.930 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2025 | 23 | 0.910 |
Why?
| | Serine | 1 | 2026 | 142 | 0.880 |
Why?
| | Fibroblasts | 5 | 2025 | 1017 | 0.860 |
Why?
| | Bezafibrate | 1 | 2024 | 10 | 0.840 |
Why?
| | Folic Acid | 1 | 2026 | 198 | 0.830 |
Why?
| | Pyridinium Compounds | 1 | 2024 | 31 | 0.830 |
Why?
| | Acidosis, Lactic | 1 | 2024 | 45 | 0.820 |
Why?
| | Alagille Syndrome | 1 | 2024 | 29 | 0.810 |
Why?
| | Niacinamide | 1 | 2024 | 86 | 0.800 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2024 | 41 | 0.800 |
Why?
| | Adenosine Triphosphate | 1 | 2025 | 500 | 0.760 |
Why?
| | Infant | 27 | 2025 | 10011 | 0.760 |
Why?
| | Glycine Dehydrogenase (Decarboxylating) | 2 | 2026 | 13 | 0.720 |
Why?
| | Leukoencephalopathies | 2 | 2019 | 24 | 0.720 |
Why?
| | Corpus Callosum | 2 | 2019 | 72 | 0.720 |
Why?
| | Biliary Atresia | 1 | 2024 | 158 | 0.720 |
Why?
| | Lysine | 5 | 2022 | 271 | 0.680 |
Why?
| | Ribosomal Proteins | 1 | 2021 | 91 | 0.660 |
Why?
| | Phenotype | 6 | 2024 | 3139 | 0.650 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2024 | 265 | 0.650 |
Why?
| | White Matter | 2 | 2019 | 153 | 0.630 |
Why?
| | Electron Transport Complex I | 1 | 2019 | 42 | 0.610 |
Why?
| | Diseases in Twins | 1 | 2019 | 115 | 0.580 |
Why?
| | Energy Metabolism | 3 | 2015 | 925 | 0.560 |
Why?
| | Arginine | 2 | 2020 | 238 | 0.550 |
Why?
| | Thalamus | 1 | 2019 | 126 | 0.550 |
Why?
| | Protein Biosynthesis | 1 | 2021 | 454 | 0.550 |
Why?
| | Magnetic Resonance Imaging | 10 | 2020 | 3879 | 0.520 |
Why?
| | Vitamin B Complex | 2 | 2015 | 40 | 0.510 |
Why?
| | Leigh Disease | 3 | 2015 | 22 | 0.510 |
Why?
| | Disease Models, Animal | 2 | 2026 | 4525 | 0.510 |
Why?
| | Infant, Newborn | 15 | 2025 | 6387 | 0.500 |
Why?
| | Mutation, Missense | 2 | 2016 | 338 | 0.500 |
Why?
| | Glycine Decarboxylase Complex | 1 | 2016 | 4 | 0.490 |
Why?
| | Aminomethyltransferase | 1 | 2016 | 6 | 0.490 |
Why?
| | Brain | 8 | 2026 | 2929 | 0.480 |
Why?
| | Oxidative Phosphorylation | 3 | 2025 | 209 | 0.450 |
Why?
| | 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.440 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.440 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2015 | 20 | 0.430 |
Why?
| | Mitochondrial Myopathies | 2 | 2023 | 10 | 0.430 |
Why?
| | Sulfurtransferases | 1 | 2013 | 9 | 0.410 |
Why?
| | Glutaredoxins | 1 | 2013 | 15 | 0.410 |
Why?
| | Spasm | 1 | 2013 | 21 | 0.400 |
Why?
| | Genetic Variation | 2 | 2021 | 982 | 0.400 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5954 | 0.380 |
Why?
| | Humans | 50 | 2026 | 144298 | 0.380 |
Why?
| | DNA Mutational Analysis | 8 | 2019 | 409 | 0.370 |
Why?
| | Neurodevelopmental Disorders | 1 | 2015 | 223 | 0.350 |
Why?
| | Channelopathies | 1 | 2011 | 5 | 0.340 |
Why?
| | Metabolic Diseases | 2 | 2010 | 114 | 0.340 |
Why?
| | Male | 29 | 2026 | 72263 | 0.340 |
Why?
| | Amino Acids | 1 | 2015 | 518 | 0.340 |
Why?
| | Liver Diseases | 2 | 2013 | 304 | 0.330 |
Why?
| | Neurotransmitter Agents | 1 | 2011 | 82 | 0.330 |
Why?
| | Succinate-CoA Ligases | 1 | 2010 | 4 | 0.330 |
Why?
| | Brain Diseases, Metabolic | 1 | 2010 | 8 | 0.320 |
Why?
| | Seizures | 3 | 2011 | 473 | 0.320 |
Why?
| | Ophthalmoplegia, Chronic Progressive External | 1 | 2009 | 3 | 0.300 |
Why?
| | Neurogenesis | 1 | 2011 | 156 | 0.300 |
Why?
| | Holocarboxylase Synthetase Deficiency | 1 | 2008 | 2 | 0.290 |
Why?
| | Carbon-Nitrogen Ligases | 1 | 2008 | 5 | 0.290 |
Why?
| | Female | 28 | 2025 | 78137 | 0.290 |
Why?
| | Nutrition Therapy | 1 | 2009 | 37 | 0.290 |
Why?
| | Biotin | 1 | 2008 | 32 | 0.280 |
Why?
| | Anticonvulsants | 2 | 2010 | 242 | 0.280 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1465 | 0.270 |
Why?
| | RNA, Transfer, Glu | 1 | 2007 | 6 | 0.270 |
Why?
| | DNA Helicases | 1 | 2009 | 141 | 0.260 |
Why?
| | Proteins | 1 | 2013 | 1011 | 0.260 |
Why?
| | Vitamin B 12 | 2 | 2021 | 127 | 0.260 |
Why?
| | Enoyl-CoA Hydratase | 2 | 2025 | 12 | 0.250 |
Why?
| | Liver | 4 | 2026 | 1884 | 0.250 |
Why?
| | Practice Guidelines as Topic | 2 | 2013 | 1565 | 0.250 |
Why?
| | Biomarkers | 4 | 2025 | 4248 | 0.250 |
Why?
| | Molecular Sequence Data | 6 | 2015 | 2896 | 0.240 |
Why?
| | GTP Cyclohydrolase | 1 | 2006 | 10 | 0.240 |
Why?
| | Paraparesis, Spastic | 1 | 2006 | 3 | 0.240 |
Why?
| | Fatal Outcome | 3 | 2013 | 305 | 0.230 |
Why?
| | RNA, Transfer, Asp | 1 | 2005 | 3 | 0.230 |
Why?
| | Dystonia | 1 | 2006 | 28 | 0.230 |
Why?
| | Parkinsonian Disorders | 1 | 2006 | 43 | 0.230 |
Why?
| | Child | 15 | 2024 | 22562 | 0.230 |
Why?
| | Hydrolysis | 1 | 2025 | 197 | 0.220 |
Why?
| | Tremor | 1 | 2006 | 98 | 0.220 |
Why?
| | Benzoic Acid | 1 | 2005 | 9 | 0.220 |
Why?
| | Child, Preschool | 11 | 2019 | 11767 | 0.220 |
Why?
| | Polymers | 1 | 2009 | 484 | 0.220 |
Why?
| | Heterozygote | 3 | 2017 | 313 | 0.220 |
Why?
| | Benzoates | 1 | 2005 | 50 | 0.220 |
Why?
| | Carnitine | 1 | 2025 | 90 | 0.220 |
Why?
| | Eye | 2 | 2019 | 110 | 0.210 |
Why?
| | Amino Acid Sequence | 5 | 2015 | 2127 | 0.210 |
Why?
| | Hydrocephalus | 2 | 2024 | 111 | 0.200 |
Why?
| | Brain Diseases | 3 | 2015 | 152 | 0.200 |
Why?
| | Dietary Supplements | 2 | 2020 | 575 | 0.200 |
Why?
| | Glucose | 1 | 2009 | 1033 | 0.200 |
Why?
| | Genotype | 3 | 2019 | 1843 | 0.200 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2003 | 17 | 0.200 |
Why?
| | Cells, Cultured | 3 | 2025 | 4102 | 0.190 |
Why?
| | Drug Combinations | 1 | 2024 | 392 | 0.190 |
Why?
| | Fibroblast Growth Factors | 1 | 2024 | 188 | 0.180 |
Why?
| | Pedigree | 3 | 2019 | 512 | 0.180 |
Why?
| | Point Mutation | 2 | 2017 | 242 | 0.170 |
Why?
| | Animals, Newborn | 1 | 2024 | 888 | 0.170 |
Why?
| | 2-Aminoadipic Acid | 2 | 2019 | 7 | 0.170 |
Why?
| | Echocardiography | 1 | 2024 | 644 | 0.170 |
Why?
| | Methionine | 1 | 2021 | 162 | 0.160 |
Why?
| | Skin | 1 | 2025 | 751 | 0.160 |
Why?
| | Mitochondrial Encephalomyopathies | 1 | 2020 | 9 | 0.160 |
Why?
| | External Capsule | 1 | 2019 | 3 | 0.160 |
Why?
| | Thymidine Phosphorylase | 1 | 2020 | 14 | 0.160 |
Why?
| | NADH Dehydrogenase | 1 | 2019 | 20 | 0.150 |
Why?
| | Hippocampus | 1 | 2026 | 964 | 0.150 |
Why?
| | Adolescent | 10 | 2020 | 22370 | 0.150 |
Why?
| | Porencephaly | 1 | 2019 | 6 | 0.150 |
Why?
| | Collagen Type IV | 1 | 2019 | 27 | 0.150 |
Why?
| | Twins, Monozygotic | 1 | 2019 | 134 | 0.150 |
Why?
| | Mice | 4 | 2026 | 18218 | 0.140 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 2 | 2021 | 25 | 0.140 |
Why?
| | Spectrum Analysis | 1 | 2019 | 91 | 0.140 |
Why?
| | Proteomics | 2 | 2024 | 1182 | 0.140 |
Why?
| | Lactic Acid | 1 | 2019 | 301 | 0.140 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 197 | 0.130 |
Why?
| | Cell Respiration | 2 | 2015 | 105 | 0.130 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2019 | 623 | 0.130 |
Why?
| | Animals | 5 | 2026 | 37800 | 0.120 |
Why?
| | Acyl-CoA Dehydrogenase | 2 | 2009 | 8 | 0.120 |
Why?
| | Dihydrolipoamide Dehydrogenase | 1 | 2016 | 6 | 0.120 |
Why?
| | Cataract | 1 | 2019 | 212 | 0.120 |
Why?
| | Gene Expression | 2 | 2015 | 1474 | 0.120 |
Why?
| | Acyl Coenzyme A | 1 | 2015 | 32 | 0.110 |
Why?
| | Introns | 1 | 2016 | 254 | 0.110 |
Why?
| | COS Cells | 1 | 2015 | 177 | 0.110 |
Why?
| | Lysosomal Storage Diseases | 1 | 2015 | 5 | 0.110 |
Why?
| | Diet Therapy | 1 | 2015 | 36 | 0.110 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2015 | 32 | 0.110 |
Why?
| | Dyskinesias | 1 | 2015 | 20 | 0.110 |
Why?
| | Exons | 1 | 2016 | 359 | 0.110 |
Why?
| | Cerebrospinal Fluid | 1 | 2015 | 88 | 0.110 |
Why?
| | Prognosis | 2 | 2015 | 4293 | 0.110 |
Why?
| | Electron Transport | 1 | 2015 | 115 | 0.110 |
Why?
| | Base Sequence | 2 | 2010 | 2171 | 0.110 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 362 | 0.110 |
Why?
| | Demyelinating Diseases | 1 | 2015 | 84 | 0.100 |
Why?
| | Cell Line | 1 | 2019 | 2821 | 0.100 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 93 | 0.100 |
Why?
| | Muscles | 1 | 2015 | 332 | 0.100 |
Why?
| | Host Cell Factor C1 | 1 | 2013 | 15 | 0.100 |
Why?
| | Genes, X-Linked | 1 | 2013 | 21 | 0.100 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 27 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 3 | 2013 | 2348 | 0.100 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2013 | 25 | 0.100 |
Why?
| | Cytochrome-c Oxidase Deficiency | 1 | 2013 | 4 | 0.100 |
Why?
| | Genetic Testing | 1 | 2016 | 479 | 0.100 |
Why?
| | Treatment Outcome | 6 | 2023 | 11713 | 0.100 |
Why?
| | Electron Transport Complex II | 1 | 2013 | 28 | 0.100 |
Why?
| | Atrophy | 1 | 2013 | 199 | 0.100 |
Why?
| | Stilbenes | 1 | 2013 | 33 | 0.100 |
Why?
| | Alleles | 1 | 2016 | 881 | 0.100 |
Why?
| | Sequence Alignment | 2 | 2015 | 368 | 0.090 |
Why?
| | Liver Transplantation | 1 | 2020 | 826 | 0.090 |
Why?
| | DNA | 1 | 2019 | 1444 | 0.090 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1044 | 0.090 |
Why?
| | Genetic Association Studies | 2 | 2010 | 369 | 0.090 |
Why?
| | Urea Cycle Disorders, Inborn | 1 | 2011 | 26 | 0.090 |
Why?
| | Vitamin B 6 | 1 | 2011 | 11 | 0.090 |
Why?
| | Time | 1 | 2011 | 86 | 0.090 |
Why?
| | Cystathionine beta-Synthase | 1 | 2011 | 65 | 0.080 |
Why?
| | Quality of Life | 1 | 2023 | 3180 | 0.080 |
Why?
| | Age of Onset | 3 | 2013 | 551 | 0.080 |
Why?
| | Homocystinuria | 1 | 2011 | 62 | 0.080 |
Why?
| | Sirtuin 3 | 1 | 2011 | 58 | 0.080 |
Why?
| | Diffuse Cerebral Sclerosis of Schilder | 1 | 2010 | 4 | 0.080 |
Why?
| | Chemokines | 1 | 2011 | 217 | 0.080 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2010 | 48 | 0.080 |
Why?
| | Prenatal Diagnosis | 1 | 2011 | 195 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2113 | 0.080 |
Why?
| | Adult | 7 | 2021 | 40408 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 927 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2019 | 17104 | 0.080 |
Why?
| | Biogenic Monoamines | 1 | 2009 | 15 | 0.070 |
Why?
| | Gene Frequency | 1 | 2010 | 480 | 0.070 |
Why?
| | Structure-Activity Relationship | 1 | 2010 | 564 | 0.070 |
Why?
| | Leucovorin | 1 | 2009 | 100 | 0.070 |
Why?
| | Neonatal Screening | 1 | 2010 | 179 | 0.070 |
Why?
| | Sequence Deletion | 1 | 2009 | 190 | 0.070 |
Why?
| | Quality Assurance, Health Care | 1 | 2010 | 341 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2009 | 246 | 0.070 |
Why?
| | Nervous System Diseases | 1 | 2011 | 283 | 0.070 |
Why?
| | Fatty Liver | 1 | 2011 | 250 | 0.070 |
Why?
| | Pregnancy Complications | 2 | 2011 | 586 | 0.070 |
Why?
| | Developmental Disabilities | 1 | 2010 | 279 | 0.060 |
Why?
| | Protein Conformation | 1 | 2010 | 935 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5862 | 0.060 |
Why?
| | Diagnosis, Differential | 1 | 2011 | 1501 | 0.060 |
Why?
| | Reflex, Abnormal | 1 | 2006 | 8 | 0.060 |
Why?
| | Consensus | 2 | 2020 | 475 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2917 | 0.060 |
Why?
| | Phenylalanine | 1 | 2006 | 70 | 0.060 |
Why?
| | Tendinopathy | 1 | 2006 | 32 | 0.060 |
Why?
| | Diet | 3 | 2012 | 1270 | 0.060 |
Why?
| | Models, Molecular | 1 | 2010 | 1607 | 0.060 |
Why?
| | Sodium Benzoate | 1 | 2005 | 5 | 0.060 |
Why?
| | Kinetics | 1 | 2008 | 1603 | 0.060 |
Why?
| | Amino Acid Oxidoreductases | 1 | 2005 | 19 | 0.060 |
Why?
| | Transferases | 1 | 2005 | 27 | 0.050 |
Why?
| | Psychomotor Disorders | 1 | 2004 | 15 | 0.050 |
Why?
| | Syndrome | 1 | 2006 | 378 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2005 | 65 | 0.050 |
Why?
| | Motor Skills Disorders | 1 | 2005 | 25 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2011 | 5404 | 0.050 |
Why?
| | Physicians | 1 | 2013 | 948 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 1 | 2013 | 1359 | 0.050 |
Why?
| | Dried Blood Spot Testing | 1 | 2025 | 126 | 0.050 |
Why?
| | Young Adult | 2 | 2011 | 14092 | 0.050 |
Why?
| | Merozoite Surface Protein 1 | 1 | 2023 | 4 | 0.050 |
Why?
| | Stereoisomerism | 1 | 2003 | 101 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1046 | 0.050 |
Why?
| | Anti-Infective Agents | 1 | 2005 | 241 | 0.040 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 18 | 0.040 |
Why?
| | Biopsy | 1 | 2005 | 1078 | 0.040 |
Why?
| | Lower Extremity | 1 | 2006 | 440 | 0.040 |
Why?
| | Metabolism, Inborn Errors | 1 | 2021 | 42 | 0.040 |
Why?
| | Oligopeptides | 1 | 2023 | 266 | 0.040 |
Why?
| | Circadian Rhythm | 1 | 2006 | 510 | 0.040 |
Why?
| | Homocysteine | 1 | 2021 | 152 | 0.040 |
Why?
| | Pipecolic Acids | 2 | 2012 | 24 | 0.040 |
Why?
| | Fatigue | 1 | 2023 | 363 | 0.040 |
Why?
| | Pregnancy | 2 | 2011 | 7112 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2005 | 733 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2021 | 248 | 0.040 |
Why?
| | Thymidine | 1 | 2020 | 60 | 0.040 |
Why?
| | Colorado | 1 | 2010 | 4554 | 0.040 |
Why?
| | International Cooperation | 1 | 2020 | 197 | 0.040 |
Why?
| | Cognition | 2 | 2022 | 1262 | 0.040 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 29 | 0.040 |
Why?
| | Muscle, Skeletal | 2 | 2010 | 1784 | 0.040 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2020 | 133 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 2032 | 0.030 |
Why?
| | Age Factors | 1 | 2005 | 3324 | 0.030 |
Why?
| | Models, Biological | 1 | 2005 | 1807 | 0.030 |
Why?
| | Aminoacylation | 1 | 2015 | 14 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 675 | 0.030 |
Why?
| | RNA, Transfer | 1 | 2015 | 144 | 0.030 |
Why?
| | Exome | 1 | 2015 | 227 | 0.030 |
Why?
| | Neuroglia | 1 | 2015 | 173 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 7128 | 0.020 |
Why?
| | Citrate (si)-Synthase | 1 | 2013 | 53 | 0.020 |
Why?
| | Electron Transport Complex IV | 1 | 2013 | 62 | 0.020 |
Why?
| | Delphi Technique | 1 | 2014 | 329 | 0.020 |
Why?
| | Myelin Sheath | 1 | 2015 | 169 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 334 | 0.020 |
Why?
| | North America | 1 | 2013 | 312 | 0.020 |
Why?
| | Middle Aged | 2 | 2023 | 35892 | 0.020 |
Why?
| | Chemokine CCL4 | 1 | 2011 | 31 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 629 | 0.020 |
Why?
| | Betaine | 1 | 2011 | 65 | 0.020 |
Why?
| | Interleukin-1alpha | 1 | 2011 | 57 | 0.020 |
Why?
| | Northwestern United States | 1 | 2010 | 58 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 741 | 0.020 |
Why?
| | Southwestern United States | 1 | 2010 | 94 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 732 | 0.020 |
Why?
| | Interleukin-17 | 1 | 2011 | 118 | 0.020 |
Why?
| | Patient Care Management | 1 | 2010 | 56 | 0.020 |
Why?
| | Public Health Practice | 1 | 2010 | 63 | 0.020 |
Why?
| | DNA Polymerase gamma | 1 | 2010 | 8 | 0.020 |
Why?
| | Acetylation | 1 | 2011 | 244 | 0.020 |
Why?
| | Binding Sites | 1 | 2013 | 1306 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2013 | 428 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2011 | 390 | 0.020 |
Why?
| | Family Health | 1 | 2010 | 191 | 0.020 |
Why?
| | Aged | 1 | 2009 | 25901 | 0.020 |
Why?
| | Information Dissemination | 1 | 2010 | 222 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 2010 | 217 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2010 | 463 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2010 | 741 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2011 | 522 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 2241 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2011 | 770 | 0.020 |
Why?
| | Linear Models | 1 | 2009 | 845 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1990 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1206 | 0.010 |
Why?
| | Tandem Mass Spectrometry | 1 | 2009 | 565 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2011 | 2177 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2013 | 2808 | 0.010 |
Why?
| | Myoclonic Epilepsy, Juvenile | 1 | 2004 | 1 | 0.010 |
Why?
| | Agenesis of Corpus Callosum | 1 | 2004 | 13 | 0.010 |
Why?
| | Nystagmus, Pathologic | 1 | 2004 | 19 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2940 | 0.010 |
Why?
| | Apnea | 1 | 2004 | 25 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2589 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2011 | 3106 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3408 | 0.010 |
Why?
| | Health Surveys | 1 | 2004 | 516 | 0.010 |
Why?
| | Survival Analysis | 1 | 2004 | 1368 | 0.010 |
Why?
| | Respiration, Artificial | 1 | 2004 | 709 | 0.010 |
Why?
| | Sex Factors | 1 | 2004 | 2103 | 0.010 |
Why?
| | Disease Progression | 1 | 2004 | 2844 | 0.010 |
Why?
| | Registries | 1 | 2004 | 2389 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2004 | 6035 | 0.010 |
Why?
|
|
Van Hove's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|